Main content

Biomedical Research Foundation, Academy of Athens 

Further Information :

General Description

The Biomedical Research Foundation of the Academy of Athens (BRFAA) is one of the leading research institutions in Greece dedicated to understanding, treating, and preventing human ailments through biomedical research. BRFAA seeks to serve science and medicine, and to participate fully in global innovation through its commitment to the integration of biology, medicine, and informatics. Established by the Academy of Athens, the Foundation accommodates state-of-the-art facilities over a 25.000 square meter area for conducting internationally competitive biomedical research.
In particular, the BRFAA Proteomics Research Unit is equipped with multiple state-of the art proteomics technologies to be employed in the TransBioBC project, including systems for two-dimensional electrophoresis, liquid chromatography (HPLC, FPLC), preparative protein electrophoresis, spot pickers for automated spot excision, matrix assisted laser desorption-ionization time-of-flight mass spectrometer (MALDI-TOF/TOF) with imaging MS capabilities etc.

Key Personnel

Dr. Antonia Vlahou, Ph.D. is the Group Leader and Co-Director of the Proteomics Research Unit at BRFAA. She received her B.Sc. degree from the School of Biology at the University of Athens, Greece and holds a Ph.D. in cell biology from Baylor College of Medicine, Houston, USA. Dr. Vlahou pursued post-doctoral studies at the Eastern VA Medical School, VA, where she was appointed as a research assistant professor from 2001 until 2003. During her doctoral and post-doctoral studies Dr. Vlahou received various awards including an award for best oral presentation, Southwestern Developmental Biology Conference, the AFUD/AUA fellowship (1998-2000) as well as the Pfizer Scholar in Urology award (2000). Dr Vlahou is one of the founding members of the Hellenic Proteomics Society and has served as the General Secretary and President of the Society. She is the organizer of proteomics courses of 3 masters programs in Athens and Crete. She has more than 10 years experience in clinical proteomics and has played a leading role in the development of standardized approaches in biomarker discovery. Among her distinctions is the Pfizer Scholar in Urology award and her role as the Chair of the Management Committee of the European Kidney and Urine Proteomics COST Action (; 2008-2012). Dr Vlahou has also served as a partner in the FP7 DECanBIO project (2008-2012) and is currently a partner in the Marie Curie IAPP ProtoClin, and EID BCMolMed, and FP7 NEURINOX projects. She serves as the Coordinator of the TransBioBC project.

Elena Critselis, B.Sc., M.P.H., Ph.D. completed her undergraduate degree in Nutritional Sciences at Cornell University, USA, and dual Master of Public Health degrees in Chronic Disease Epidemiology and Global Health at Yale University, USA. She received her PhD in Nutrition – Epidemiology at Harokopio University. Following a Fellowship at the WHO European Regional Office (Copenhagen, Denmark), she returned to Greece and served as a long-standing Nutritional-Epidemiologist at the WHO Collaborating Center for Food and Nutrition Policies and the University of Athens Medical School. She was appointed Associate Scientific Director of The "Stavros Niarchos" Foundation Collaborative Center for Clinical Epidemiology at the University of Athens Medical School. She has taught undergraduate and graduate courses in Epidemiology, Biostatistics, and Public Health Policy at Harokopio University and the University of Athens Medical School. She has participated in several international multicenter studies funded by the European Sixth and Seventh Framework Programmes, as well as the National Institutes of Health, USA. The culmination of her work has been published in international peer-reviewed journals (>600 citations, h-index: 12). Dr Critselis is a dual "Alexander S. Onassis" Public Benefit Foundation Scholar, dual Cornell University Dean's List Recipient, as well as recipient of several national and international scientific society awards.

Jerome Zoidakis, Ph.D. was born in Mons, Belgium and grew up in Athens, Greece. He obtained his Candidature in Biology and Maitrise in Biochemistry from the University of Liege, Belgium. The focus of his doctoral research at UCLA was on Bioinorganic Chemistry and particularly the enzyme Phenylalanine Hydroxylase. His post-doctoral research conducted at the proteomics lab of the Biomedical Research Foundation, Academy of Athens, focused on Bladder Cancer. He is currently a senior research fellow in Dr. Vlahou's proteomics lab at BRFAA .